| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/BIT.23138 |
| P698 | PubMed publication ID | 21437880 |
| P2093 | author name string | A Ross | |
| K Bohle | |||
| P2860 | cites work | Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes. | Q30376672 |
| Prospects for control of emerging infectious diseases with plasmid DNA vaccines. | Q30380454 | ||
| Plasmid R1--replication and its control | Q36274445 | ||
| DNA vaccines: recent developments and future possibilities | Q36619614 | ||
| Gene therapy clinical trials worldwide to 2007--an update. | Q36920192 | ||
| Process analytical technology (PAT) for biopharmaceutical products: Part I. concepts and applications | Q37592066 | ||
| Control of replication of bacterial plasmids: Genetics, molecular biology, and physiology of the plasmid R1 system | Q40112314 | ||
| Kinetic aspects of control of plasmid replication by antisense RNA. | Q40682089 | ||
| Replication of the prophage P1 during the cell cycle of Escherichia coli | Q40775086 | ||
| Effect of the bacterial growth rate on replication control of plasmid pBR322 in Escherichia coli | Q42096558 | ||
| Characterization of the metabolic burden on Escherichia coli DH1 cells imposed by the presence of a plasmid containing a gene therapy sequence | Q45143240 | ||
| High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation | Q45879752 | ||
| Cellular plasmid content and cloned-gene expression: some useful equations | Q46864471 | ||
| Kinetic study of instability of recombinant plasmid pPLc23trpAl in E. coli using two-stage continuous culture system | Q46907453 | ||
| Effects of recombinant plasmid content on growth properties and cloned gene product formation in Escherichia coli | Q46961399 | ||
| DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice. | Q47831384 | ||
| Plasmid-encoded protein: the principal factor in the "metabolic burden" associated with recombinant bacteria | Q47869692 | ||
| A kinetic model for product formation in unstable recombinant populations | Q47871754 | ||
| Requirements for rapid plasmid ColE1 copy number adjustments: a mathematical model of inhibition modes and RNA turnover rates. | Q52243526 | ||
| Investigation of subpopulation heterogeneity and plasmid stability in recombinant escherichia coli via a simple segregated model. | Q52394849 | ||
| Quantitative Model of ColE1 Plasmid Copy Number Control | Q52400715 | ||
| ColE1 plasmid replication: a simple kinetic description from a structured model. | Q52510929 | ||
| On the kinetics of plasmid replication. | Q53849202 | ||
| Studies of host-plasmid interactions in recombinant microorganisms. | Q54786508 | ||
| Role of the Rom Protein in Copy Number Control of Plasmid pBR322 at Different Growth Rates inEscherichia coliK-12 | Q57695264 | ||
| P433 | issue | 9 | |
| P921 | main subject | DNA design | Q55213961 |
| P304 | page(s) | 2099-2106 | |
| P577 | publication date | 2011-05-24 | |
| P1433 | published in | Biotechnology and Bioengineering | Q4915339 |
| P1476 | title | Plasmid DNA production for pharmaceutical use: role of specific growth rate and impact on process design | |
| P478 | volume | 108 |
| Q58576673 | Optimization of fermentation conditions for an strain engineered using the response surface method to produce a novel therapeutic DNA vaccine for rheumatoid arthritis |
| Q51797850 | Physiological effects of pH gradients on Escherichia coli during plasmid DNA production. |
| Q45871951 | Plasmid DNA primary recovery from E. coli lysates by depth bed microfiltration. |
| Q40425661 | Plasmid pVAX1-NH36 purification by membrane and bead perfusion chromatography |
| Q41628326 | Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production |
Search more.